Bright Minds Biosciences Inc. Common Stock logo

DRUG Earnings Date: Dec 22, 2026 (Estimated) — Bright Minds Biosciences Inc. Common Stock

XNAS

Updated

Price $56.69
Market Cap $551.7M
P/E —
52W Range $47.23 – $123.75
Next Earnings (est.)

When is DRUG's next earnings date?

Bright Minds Biosciences Inc. Common Stock (DRUG) is expected to report earnings on Tuesday, December 22, 2026; the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$1.15.

How did DRUG do in its last earnings report?

In its most recent report on Aug 17, 2026 (Q3 2026), Bright Minds Biosciences Inc. Common Stock posted EPS of -$0.17 versus the -$1.39 estimate, a beat of 87.8%. Revenue was $0. The stock's 1-day post-earnings move was +4.0%.

How much does DRUG stock move after earnings?

DRUG beat EPS estimates in 3 of its last 3 reported quarters. Over the last 7 reports the stock moved an average of 3.6% (up or down) in the day after earnings.

About Bright Minds Biosciences Inc. Common Stock

Bright Minds Biosciences Inc is focused on developing novel, transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult-to-treat disorders such as resistant epilepsy, treatment-resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.

Earnings History

DatePeriodEPS Est.EPS Act.SurpriseRevenueResult1D Δ1W Δ1M Δ
2026-08-17Q3 2026-1.39-0.17+87.77%$0✅ Beat+3.98%+1.28%-21.22%
2026-02-13Q4 2025-1.34-0.97+27.61%$0✅ Beat-3.31%+6.09%-9.13%
2025-08-11Q3 2025-0.59-0.42+28.81%$0✅ Beat-0.18%+7.73%+8.63%
2025-02-14Q1 2025—0.01—$0—-10.26%-14.02%-14.67%
2024-12-31Q4 2024—-0.12—$0—-2.28%+9.12%-7.76%
2024-08-14Q3 2024—0.05—$0—-3.81%-3.81%+19.05%
2024-02-13Q1 2024—-0.44—$0—+1.30%-3.37%-32.64%
2022-12-28—-0.15——————

Showing last 8 quarters.

Learn More

Explore More

Financial data from licensed market-data providers; risk factors from SEC EDGAR filings. AI-powered analysis. Data last updated .